{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T21:57:21Z","timestamp":1697666241000},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1007\/s10620-005-3049-z","type":"journal-article","created":{"date-parts":[[2006,1,13]],"date-time":"2006-01-13T09:39:23Z","timestamp":1137145163000},"page":"2286-2295","source":"Crossref","is-referenced-by-count":15,"title":["Natural Course of Functional Dyspepsia After Helicobacter pyloriEradication: A Seven-Year Survey"],"prefix":"10.1007","volume":"50","author":[{"given":"Francesco Di","family":"Mario","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicoletta","family":"Stefani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadia Dal","family":"B\u00f2","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Rugge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Pilotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia Martina","family":"Cavestro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucas Giovanni","family":"Cavallaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo","family":"Franz\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gioacchino","family":"Leandro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"3049_CR1","doi-asserted-by":"crossref","first-page":"II37","DOI":"10.1136\/gut.45.2008.ii37","volume":"45","author":"NJ Talley","year":"1999","unstructured":"Talley NJ, Stanghellini V, Heading RC: Functional gastroduodenal disorders. Gut 45 (Suppl II):II37\u2013II42, 1999","journal-title":"Gut"},{"key":"3049_CR2","doi-asserted-by":"crossref","first-page":"312","DOI":"10.2165\/00019053-199201050-00003","volume":"1","author":"O Nyren","year":"1992","unstructured":"Nyren O, Lindberg G, Lindstrom E, Marke LA, Seensalu R: Economic costs of functional dyspepsia. Pharmacoeconomics 1:312\u2013324, 1992","journal-title":"Pharmacoeconomics"},{"key":"3049_CR3","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1007\/BF01303162","volume":"38","author":"DA Drossman","year":"1993","unstructured":"Drossman DA, Li Z, Andruzzi E, et al.: U.S. householder survey of functional gastrointestinal disorders: Prevalence, sociodemography and health impact. Dig Dis Sci 38:1569\u20131580, 1993","journal-title":"Dig Dis Sci"},{"key":"3049_CR4","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1136\/bmj.319.7216.1040","volume":"319","author":"RL Jaakkimainen","year":"1999","unstructured":"Jaakkimainen RL, Boyle E, Tudiver F: Is Helicobacter pylori associated with non-ulcer dyspepsia and will eradication improve symptoms? A meta-analysis. Br Med J 319:1040\u20131044, 1999","journal-title":"Br Med J"},{"key":"3049_CR5","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0140-6736(00)90005-9","volume":"355","author":"J Danesh","year":"2000","unstructured":"Danesh J, Pounder RE: Eradication of Helicobacter pylori and non-ulcer dyspepsia. Lancet 355:766\u2013777, 2000","journal-title":"Lancet"},{"key":"3049_CR6","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1365-2036.2004.01897.x","volume":"19","author":"HB El-Serag","year":"2004","unstructured":"El-Serag HB, Talley NJ: Systematic review: The prevalence and clinical course of functional dyspepsia. Aliment Pharmacol Ther 19:643\u2013654, 2004","journal-title":"Aliment Pharmacol Ther"},{"key":"3049_CR7","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/BF01211369","volume":"30","author":"M Kawanishi","year":"1995","unstructured":"Kawanishi M, Fukuda S, Kawaguchi H, Kohmoto K, Kajiyama G: Significance of rapid urease test for identification of Helicobacter pylori in comparison with histological and culture studies. J Gastroenterol 30:16\u201320, 1995","journal-title":"J Gastroenterol"},{"key":"3049_CR8","first-page":"576","volume":"1","author":"DG Colin-Jones","year":"1988","unstructured":"Colin-Jones DG, Bloom B, Bodemar G, et al.: Management of dyspepsia: Report of a working party. Lancet 1:576\u2013579, 1988","journal-title":"Lancet"},{"key":"3049_CR9","volume-title":"Schistosomes, liver flukes and Helicobacter pylori. IARC monographs on the evaluation of carcinogenic risks to humans. Volume 61","author":"International Agency for Research on Cancer","year":"1994","unstructured":"International Agency for Research on Cancer: Schistosomes, liver flukes and Helicobacter pylori. IARC monographs on the evaluation of carcinogenic risks to humans. Volume 61. Lyon, France: International Agency for Research on Cancer, 1994"},{"key":"3049_CR10","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF02774552","volume":"17","author":"O Bonnevie","year":"1982","unstructured":"Bonnevie O: Outcome of non-ulcer disease. Scand J Gastroenterol 17 (Suppl 79):135\u2013138, 1982","journal-title":"Scand J Gastroenterol"},{"key":"3049_CR11","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/0016-5085(87)90983-8","volume":"92","author":"NJ Talley","year":"1987","unstructured":"Talley NJ, McNeill D, Hayen A, Colreavy C, Piper DW: Prognosis of chronic unexplained dyspepsia. A prospective study of potential predictor variables in patients with endoscopically diagnosed nonulcer dyspepsia. Gastroenterology 92:1060\u20131066, 1987","journal-title":"Gastroenterology"},{"key":"3049_CR12","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3109\/00365528709078590","volume":"22","author":"NJ Talley","year":"1987","unstructured":"Talley NJ, Piper DW: A prospective study of social factors and major life event stress in patients with dyspepsia of unknown cause. Scand J Gastroenterol 22:268\u2013272, 1987","journal-title":"Scand J Gastroenterol"},{"key":"3049_CR13","doi-asserted-by":"crossref","first-page":"440","DOI":"10.3109\/00365528909093072","volume":"24","author":"H Sloth","year":"1989","unstructured":"Sloth H, Jorgensen LS: Predictors for the course of chronic non-organic upper abdominal pain. Scand J Gastroenterol 24:440\u2013444, 1989","journal-title":"Scand J Gastroenterol"},{"key":"3049_CR14","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/00005176-200004000-00012","volume":"30","author":"JS Hyams","year":"2000","unstructured":"Hyams JS, Davis P, Sylvester FA, Zeiter DK, Justinich CJ, Lerer T: Dyspepsia in children and adolescents: A prospective study. J Pediatr Gastroenterol Nutr 30:413\u2013418, 2000","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"3049_CR15","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1046\/j.1365-2036.2003.01685.x","volume":"18","author":"M Heikkinen","year":"2003","unstructured":"Heikkinen M, Farkkila M: What is the long-term outcome of the different subgroups of functional dyspepsia? Aliment Pharmacol Ther 18:223\u2013229, 2003","journal-title":"Aliment Pharmacol Ther"},{"key":"3049_CR16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/gut.51.1.15","volume":"51","author":"PI Hsu","year":"2002","unstructured":"Hsu PI, Lai KH, Lo GH, et al.: Risk factors for ulcer development in patients with non-ulcer dispepsia: A prospective two year follow up study of 209 patients. Gut 51:15\u201320, 2002","journal-title":"Gut"},{"key":"3049_CR17","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/BF02063953","volume":"40","author":"C Mc Carthy","year":"1995","unstructured":"Mc Carthy C, Patchett S, Collins RM, et al.: Long-term prospective study of Helicobacter pylori in nonulcer dyspepsia. Dig Dis Sci 40:114\u2013119, 1995","journal-title":"Dig Dis Sci"},{"key":"3049_CR18","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3109\/00365529709025095","volume":"32","author":"J Gilvarry","year":"1997","unstructured":"Gilvarry J, Buckley MJ, Beattie S, et al.: Eradication of Helicobacter pylori affects symptoms in non-ulcer dyspepsia. Scand J Gastroenterol 32:535\u2013540, 1997","journal-title":"Scand J Gastroenterol"},{"key":"3049_CR19","first-page":"441","volume":"91","author":"Bs Sheu","year":"1996","unstructured":"Sheu Bs, Lin CY, Lin XZ, et al.: Long-term outcome of triple therapy in Helicobacter pylori related non-ulcer dyspepsia: A prospective controlled assessment. Am J Gastroenterol 91:441\u2013447, 1996","journal-title":"Am J Gastroenterol"},{"key":"3049_CR20","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1007\/BF02087905","volume":"41","author":"M Lazzaroni","year":"1996","unstructured":"Lazzaroni M, Bargiggia S, Sangaletti O, et al.: Eradication of Helicobacter pylori and long-term outcome of functional dyspepsia. A clinical endoscopic study. Dig Dis Sci 41:1589\u20131594, 1996","journal-title":"Dig Dis Sci"},{"key":"3049_CR21","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1056\/NEJM199812243392601","volume":"339","author":"K McColl","year":"1998","unstructured":"McColl K, Murray L, El-Omar E, et al.: Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia. New Engl J Med 339:1869\u20131874, 1998","journal-title":"New Engl J Med"},{"key":"3049_CR22","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1136\/bmj.324.7344.1012","volume":"324","author":"N Chiba","year":"2002","unstructured":"Chiba N, Veldhuyzen van Zanten SJO, Sinclair P, Ferguson RA, Escobedo S, Grace E: Treating Helicobacter pylori infection in primary care patients with univestigated dyspepsia: The Canadian adult dyspepsia empiric treatment\u2013Helicobacter pylori positive(CADET-Hp) randomised controlled trial. Br Med J 324:1012, 2002","journal-title":"Br Med J"},{"key":"3049_CR23","first-page":"1089","volume":"90","author":"GH Elta","year":"1995","unstructured":"Elta GH, Scheiman JM, Barnett JL, et al.: Long-term follow-up of Helicobacter treatment in non-ulcer dyspepsia patients. Am J Gastroenterol 90:1089\u20131093, 1995","journal-title":"Am J Gastroenterol"},{"key":"3049_CR24","doi-asserted-by":"crossref","first-page":"A250","DOI":"10.1016\/0016-5085(95)23660-0","volume":"108","author":"SJ Veldhuyzen Zanten van","year":"1995","unstructured":"Veldhuyzen van Zanten SJ, Malatjalian D: The effect of eradication of Helicobacter pylor of symptoms of non-ulcer dyspepsia (NUD). A randomized, double-blind placebo-controlled trial. Gastroenterology 108:A250, 1995","journal-title":"Gastroenterology"},{"key":"3049_CR25","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1001\/archinte.159.19.2283","volume":"159","author":"PD Greenberg","year":"1999","unstructured":"Greenberg PD, Cello P: Lack of effect of treatment for Helicobacter pylori on symptoms of nonulcer dyspepsia. Arch Intern Med 159:2283\u20132288, 1999","journal-title":"Arch Intern Med"},{"issue":"2","key":"3049_CR26","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S1590-8658(01)80066-9","volume":"33","author":"CH Chuang","year":"2001","unstructured":"Chuang CH, Sheu BS, Yang HB, et al.: Ranitidine bismuth citrate or omeprazole-based triple therapy for Helicobacter pylori eradication in Helicobacter pylori-infected non-ulcer dyspepsia. Dig Liver Dis 33(2):125\u2013130, 2001","journal-title":"Dig Liver Dis"},{"key":"3049_CR27","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1056\/NEJM199812243392602","volume":"339","author":"AL Blum","year":"1998","unstructured":"Blum AL, Talley NJ, O'Morain C, et al.: Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus clarithromycin and amoxicillin effect one year after treatment (OCAY) study group. N Engl J Med 339:1875\u20131881, 1998","journal-title":"N Engl J Med"},{"key":"3049_CR28","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1111\/j.1572-0241.2001.04037.x","volume":"96","author":"F Froelich","year":"2001","unstructured":"Froelich F, Gonvers JJ, Wietlisbach V, et al.: Helicobacter pylori eradication treatment does not benefit patients with nonulcer dyspepsia. Am J Gastroenterol 96:2329\u20132336, 2001","journal-title":"Am J Gastroenterol"},{"key":"3049_CR29","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1136\/bmj.318.7187.833","volume":"18","author":"NJ Talley","year":"1999","unstructured":"Talley NJ, Janssens J, Lauritsen K, Racz I, Bolling-Sternevald E: Eradication of Helicobacter pylori in functional dyspepsia: Randomised double blind placebo controlled trial with 12 months' follow up. Br Med J 18:833\u2013837, 1999","journal-title":"Br Med J"},{"key":"3049_CR30","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1056\/NEJM199910073411502","volume":"341","author":"NJ Talley","year":"1999","unstructured":"Talley NJ, Vakil N, Ballard ED, Fennery MB: Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia. N Engl J Med 341:1106, 1999","journal-title":"N Engl J Med"},{"key":"3049_CR31","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1136\/bmj.321.7262.659","volume":"321","author":"P Moayyedi","year":"2000","unstructured":"Moayyedi P, Soo S, Deeks J, et al.: Systematic review and economic evaluation of Helicobacter pylori eradication treatment of non\u2013ulcer dyspepsia. Br Med J 321:659\u2013664, 2000","journal-title":"Br Med J"},{"key":"3049_CR32","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1046\/j.1365-2036.2003.01575.x","volume":"17","author":"P Moayyedi","year":"2003","unstructured":"Moayyedi P, Soo S, Deeks J, et al.: Systematic review: Antacids, H2-receptor antagonists, prokinetics, bismuth and sucralfate therapy for non-ulcer dyspepsia. Aliment Pharmacol Ther 17:1215\u20131227, 2003","journal-title":"Aliment Pharmacol Ther"},{"key":"3049_CR33","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1046\/j.1365-2036.2001.01100.x","volume":"15","author":"D Williams","year":"2001","unstructured":"Williams D, O'Kelly P, Kelly A, Feely J: Lack of symptom benefit following presumptive Helicobacter pylori eradication therapy in primary care. Aliment Pharmacol Ther 15:1769\u20131775, 2001","journal-title":"Aliment Pharmacol Ther"},{"key":"3049_CR34","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1080\/003655202760230856","volume":"37","author":"M Heikkinen","year":"2002","unstructured":"Heikkinen M, F\u00e4rkkil\u00e4 M: Long-term outcome of functional dyspepsia: effect of Helicobacter pylori infection. A 6- to 7-year follow-up study. Scand J Gastroenterol 37:905\u2013910, 2002","journal-title":"Scand J Gastroenterol"},{"key":"3049_CR35","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1046\/j.1523-5378.2002.00104.x","volume":"7","author":"D McNamara","year":"2002","unstructured":"McNamara D, Buckley M, Gilvarry J, et al.: Does Helicobacter pylori eradication affects symptoms in nonulcer dyspepsia: A 5-year follow-up study. Helicobacter. 7:317\u2013321, 2002","journal-title":"Helicobacter"},{"key":"3049_CR36","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1155\/1999\/180751","volume":"13","author":"RH Hunt","year":"1999","unstructured":"Hunt RH, Fallone CA, Thomson AB: Canadian Helicobacter pylori consensus conference update: Infection in adults. Can J Gastroenterol 13:213\u2013217, 1999","journal-title":"Can J Gastroenterol"},{"key":"3049_CR37","volume-title":"The Functional Gastrointestinal Disorders: Diagnosis, Pathophysiology, and Treatment","year":"1994","unstructured":"Drossman DA, ed.: The Functional Gastrointestinal Disorders: Diagnosis, Pathophysiology, and Treatment. Boston, Little, Brown, 1994"},{"key":"3049_CR38","volume-title":"Rome II: The Functional Gastrointestinal Disorders: Diagnosis, Pathophysiology and Treatment\u2014A Multinational Consensus","year":"2000","unstructured":"Drossman DA, Talley NJ, Corazziari ES, Thompson WG, Whitehead WE, eds.: Rome II: The Functional Gastrointestinal Disorders: Diagnosis, Pathophysiology and Treatment\u2014A Multinational Consensus. 2nd ed. McLean, VA, Degnon Associates, 2000","edition":"2nd ed."},{"key":"3049_CR39","first-page":"S13","volume":"13","author":"EM Quigley","year":"2001","unstructured":"Quigley EM: Non-erosive reflux disease: Part of the spectrum of gastro-oesophageal reflux disease, a component of functional dyspepsia, or both? Eur J Gastroenterol Hepatol 13 (Suppl 1):S13\u2013S18, 2001","journal-title":"Eur J Gastroenterol Hepatol"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-005-3049-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-005-3049-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-005-3049-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T19:35:40Z","timestamp":1559244940000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-005-3049-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":39,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["3049"],"URL":"https:\/\/doi.org\/10.1007\/s10620-005-3049-z","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}